Abstract
Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis, nasal polyposis, asthma and precipitation of asthma, and rhinitis attacks after ingestion of aspirin (ASA) and most other nonsteroidal antiinflammatory drugs (NSAIDs). Although precipitation of asthma attacks by ingestion of ASA and other NSAIDs is considered a hallmark of the syndrome, the respiratory mucosal inflammatory disease process begins and continues in the absence of ongoing or even intermittent exposure to ASA or NSAIDs. The typical patient with AERD is an adult who develops refractory chronic rhinitis in the third or fourth decade of life. The chronic rhinitis evolves into chronic eosinophilic rhinosinusitis with associated nasal polyposis. Anosmia appears in most patients. CT of the sinuses most often demonstrates pansinusitis and patients often undergo multiple sinus operations resulting in only limited temporary benefit. During the evolution of the sinus disease persistent asthma develops. Finally, if patients are exposed to ASA or NSAIDs acute respiratory reactions begin to occur. Despite subsequent avoidance of ASA and other NSAIDs, the respiratory mucosal inflammatory disease persists, often requiring systemic corticosteroids for control of both upper- and lower-respiratory tract symptoms. Adequate control of asthma can often only be accomplished with the simultaneous control of the associated rhinosinusitis. With few exceptions, once AERD develops it remains for the remainder of the patient’s life.
Similar content being viewed by others
References
Stevenson, D., and Simon, R. A. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs, in Allergy: Principles and Practice, Middleton, Jr., E., Ellis, E. F. Yunginger, J. W., Reed, C. E., Adkinson, N. F., Jr., and Busse, W. W., eds., vol. 2, 5th ed. Mosby, St. Louis, 1998, pp. 1225–1234.
Stevenson, D. D. (2001), Anaphylactic and anaphylactoid reactions to aspirin and nonsteroidal anti-inflammatory drugs. Immunology and Allergy Clinics of North America 21, 745–768.
Czerniawska-Mysik, G., and Szczeklik, A. (1981), Idiosyncrasy to pyrazolone drugs. Allergy 36, 381–384.
Stevenson, D. D. (1995), Aspirin and nonsteroidal antiinflammatory drugs. Immunology and Allergy Clinics of North America 15, 529–549.
Quiralte, J., Blanco, C., Castillo, R., Ortega, N., and Carrillo, T. (1997), Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann. Allergy Asthma Immunol. 78, 293–296.
Stevenson, D. (1998), Adverse reactions to nonsteroidal antiinflammatory drugs. N. American Clinics Allergy and Immunology 18:4, 773–798.
Settipane, R. A., and Stevenson, D. D. (1989), Cross sensitivity with acetaminophen in aspirin sensitive asthmatics. J. Allergy and Clin. Immunol. 84, 26–33.
Stevenson, D. D., Hougham, A., Schrank, P., Goldlust, B., and Wilson, R. (1990), Disalcid cross-sensitivity in aspirin sensitive asthmatics. J. Allergy Clin. Immunol. 86, 749–758.
Stevenson, D. D., Simon, R. A., Lumry, W. R., and Mathison, D. A. (1986), Adverse reactions to tartrazine. J. Allergy Clin. Immunol. 78, 182–191.
Stevenson, D. D. and Simon, R. A. Sulfite induced asthma, in Current Therapy in Internal Medicine, Bayless, Brain, and Cherniack, eds., B.C., 1987, pp. 14-10.
Feigenbaum, B. A., Stevenson, D. D., and Simon, R. A. (1995), Lack of cross-sensitivity to IV hydrocortisone in aspirin-sensitive subjects with asthma. J. Allergy Clin. Immunol. 96, 545–548.
Woessner, K., Simon, R. A., and Stevenson, D. D. (1999), Monosodium glutamate sensitivity in asthma. J. Allergy Clin. Immunol. 104, 305–310.
Stevenson, D., and Simon, R. A. (2001), Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J. Allergy Clin. Immunol. 108, 47–51.
Woessner, K., Simon, R. A., and Stevenson, D. D. (2002), The safety of celecoxib in aspirin exacer-bated respiratory disease. Arthritis Rheum. 46, 2201–2206.
Sanchez-Borges, M., Capriles-Hulett, A., Caballero-Fonseca, F., and Ramon-Perez, C. (2001), Tolerability to new Cox-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann. Allergy Asthma Immunol. 87, 201–204.
Pacor, M., Di Lorenzo, G., Biasi, D., Barbagallo, M., and Corrocher, R. (2002), Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal antiinflammatory drugs. Clin. Exp. Allergy 32, 397–400.
Quiralte, J. S. dS. P., B., and Florido, J. J. (2002), Safety of selective cyclooxgenase-2 inhibitor rofecoxib in patients with NSAID-induced cutaneous reactions. Ann. Allergy Asthma Immunol. 89, 63–66.
Berges-Gimeno, M., Camacho-Garrido, E., Garcia-Rodriguez, R. M., Martin-Garcia, C., Alfaya, T., and Hinojosa, M. (2001), Rofecoxib: safe in NSAID intolerant patients. Euro. J. Allergy Clin. Immunol. 56, 1017–1018.
Berges-Gimeno, M., Simon, R. A., and Stevenson, D. D. (2002), The effect of leukotriene modifier drugs on asa-induced asthma and rhinitis reactions. Clin. Exp. Allergy (Accepted for publication.)
Zeiss, C. R., and Lockey, R. F. (1976), Refractory period to aspirin in a patient with aspirin-induced asthma. J. Allergy Clin. Immunol. 57, 440–448.
Pleskow, W. W., Stevenson, D. D., Mathison, D. A., Simon, R. A., Schatz, M., and Zieger, R. S. (1982), Aspirin desensitization in aspirin sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J. Allergy Clin. Immunol. 69, 11–19.
Widal, M. F., Abrami, P., and Lermeyez, J. (1922), Ana-phylaxie et idiosyncrasie. Presse Med. 30, 189–192.
Mathison, D. A., Lumry, W. R., and Stevenson, D. D. (1982), Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J. Allergy Clin. Immunol. 69, 135.
Slavin, R. G. (1992), Asthma and sinusitis. J. Allergy Clin. Immunol. 90, 534–537.
Mastalerz, L., Milewski, M., Duplaga, M., Nizankowska, E., and Szczeklik, A. (1997), Intranasal fluti-casone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma. Allergy 52, 895–900.
Berges-Gimeno, M., Simon, R. A., and Stevenson, D. D. (2002), The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann. Allergy Asthma Immunol. (Accepted for publication.)
Mathison, D. A., and Stevenson, D. D. Aspirin sensitivity in rhinosinusitis-asthma, in Current Therapy in Allergy, Immunology and Rheumatology, Lichtenstein, L. M., and Fauci, A. S., eds., vol. 1, 1st ed. Mosby, St. Louis, 1985, pp. 27–30.
McFadden, E. A., Woodson, B. T., Fink, J. N., and Toohill, R. J. (1997), Surgical treatment of aspirin triad sinusitis. Am. J. Rhinol. 11, 263–270.
Nakamura, H., Kawasaki, M., Higuchi, Y., and Takahashi, S. (1999), Effects of sinus surgery on asthma in aspirin triad patients. Acta Otolaryngol. 119, 592–598.
Schaitkin, B., May, M., Shapiro, A., Fucci, M., and Mester, S. J. (1993), Endoscopic sinus surgery: 4-year follow-up on the first 100 patients. Laryngoscope 103, 1117–1120.
Kennedy, D. W. (1992), Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 102, 1–18.
Stevenson, D. D., Hankammer, M. A., Mathison, D. A., Christensen, S. C., and Simon, R. A. (1986), Long term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J. Allergy Clin. Immunol. 98, 751–758.
Dahlen, B. N., Szczeklik, A., Zetterstrom, O., Bochenek, G., Kumlin, M., Mastalerz, L., et al. (1998), Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am. J. Respir. Cril. Care Med. 157, 1187–1194.
Dahlen, S., Malstrom, K., Nizankowska, E., Dahlen, B., Kuna, P., Kowalski, M. et al. (2002), Improvement of aspirin-intolerant asthma by montelukast, a leukotriene anatagonist. A randomised, double blind, placebo controlled trial. Am. J. Respir. Crit. Care Med. 165, 9–14.
Dahlen, B. (2000), Treatment of aspirin-intolerant asthma with antileukotrienes. Am. J. Respir. Crit. Care Med. 161, S137-S141.
Stevenson, D. D., Simon, R. A., and Mathison, D. A. (1980), Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J. Allergy Clin. Immunol. 66, 82–88.
Stevenson, D. D., Pleskow, W. W., Simon, R. A., Mathison, D. A., Lumry, W. R., Schatz, M., et al. (1983), Treatment of aspirin sensitive asthma rhinosinusitis with aspirin. J. Allergy Clin. Immunol. 71(2), 272–270.
Sweet, J. A., Stevenson, D. D., Simon, R. A., and Mathison, D. A. (1990), Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J. Allergy Clin. Immunol. 86, 59–65.
Patriarca, G., Bellioni, P., Nucera, E., Schiavino, D., Papa, G., Schinco, G., et al. (1991), Intranasal treatment with lysine acetylsalcylate in patients with nasal polyposis. Ann. Allergy 67, 588–593.
Widal, M. F., Abrami, P., Lermeyez, J. (1922), Anaphylaxie et idiosyncrasie. Presse Med. 30, 189–192.
Samter, M., and Beers, R., Jr. (1968), Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 68, 975–983.
Samter, M., and Beers, R. F. (1967), Concerning the nature of the intolerance to aspirin. J. Allergy 40, 281–293.
Szczeklik, A., and Stevenson, D. D. (1999), Aspirin-induced asthma: advances in pathogenesis and management. J. Allergy Clin. Immunol. 104, 5–13.
Spector, S. L., Wangaard, C. H., and Farr, R. S. (1979), Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J. Allergy Clin. Immunol. 64(6 Pt 1), 500–506.
McDonald, J., Mathison, D. A., and Stevenson, D. D. (1972), Aspirin intolerance in asthma—detection by challenge. J. Allergy Clin. Immunol. 50, 198–207.
Weber, R. W., Hoffman, M., Raine, D. A., and Nelson, H. S. (1979), Incidence of bron-choconstriction due to aspirin, azo dyes, nonazo dyes, and preservatives in a population of perennial asthmatics. J. Allergy Clin. Immunol. 64, 32–37.
Falliers, C. J. (1973), Aspirin and subtypes of asthma: risk factor analysis. J. Allergy Clin. Immunol. 52, 141–147.
Raika, G., and Skog, E. (1965), On the relationship between drug allergy and atopy. Acta Allergol. 20, 387.
Schuhl, J. F., and Pereyra, J. G. (1979), Oral acety-salicylic acid (aspirin) challenge in asthmatic children. Clin. Allergy 9, 83–88.
Towns, S. J., and Mellis, C. M. (1984), Role of acetyl salicylic acid and sodium metabisulfite in chronic childhood asthma. Pediatrics 73, 631–637.
Vedanthan, P. K., Menon, M. M., Bell, T. D., and Bergin, D. (1977), Aspirin and tartrazine oral chal-lenge: incidence of adverse response in chronic childhood asthma. J. Allergy Clin. Immunol. 60, 8–13.
Rachelefsky, G. S., Coulson, A., Siegel, S. C., and Stiehm, E. R. (1975), Aspirin intolerance in chronic chilhood asthma: detection by oral challenge. Pediatrics 56, 443–448.
Szczeklik, A. and Sanak, M. (2000), Genetic mechanisms in aspirin-induced asthma. Am. J. Respir. Crit. Care Med. 161, S142-S146.
Stevenson, D. (1998), Adverse reactions to nonsteroidal anti-inflammatory drugs. N. American Clinics Allergy and Immunology 18:4, 773–798.
Stevenson, D., and Simon, R. A. (2001), Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients. J. Allergy Clin. Immunol. 108, 47–51.
Picado, C., Castillo, J. A., Montserrat, J. M., and Agusti-Vidal, A. (1989), Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur. Respir. 2, 127–129.
Marquette, C., Saulnier, F., Leroy, O., Wallaert, B., Chopin, C., Demarcq, J. M., et al. (1992), Long-term prognosis for near-fatal asthma: a 6-year follow up study of 145 asthmatic patients who underwent mechanical ventilation for near fatal asthma. Am. Rev. Resp. Dis. 146, 76–81.
Stevenson, D. and Simon, R. A.. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs in Allergy: Principles and Practice, Middleton, Jr., E., Ellis, E. F., Yunginger, J. W., Reed, C. E., Adkinson, Jr. N. F., and Busse, W. W., eds., vol. 2, 5th ed., Mosby, St. Louis, 1998, pp. 1225–1234.
Pleskow, W. W., Stevenson, D. D., Mathison, D. A., Simon, R. A., Schatz, M., and Zieger, R. S. (1983), Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J. Allergy Clin. Immunol. 71, 574–579.
Bosso, J. V., Schwartz, L. B., and Stevenson, D. D. (1991), Tryptase and histamine release during aspirin-induced respiratory reactions. J. Allergy Clin. Immunol. 88, 830–837.
Berges-Gimeno, M., Simon, R. A., and Stevenson, D. D. (2002), The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann. Allergy Asthma Immunol. (Accepted for publication).
Nizankowska, E. and Szczeklik, A. (1989), Glucocorticosteroids attenuate aspirin-precipitated adverse reactions in aspirin-intolerant patients with asthma. Ann. Allergy 63, 159–162.
Stevenson, D., Simon, R. A., Mathison, D. A., and Christiansen, S. C. (2000), Montelukast is only partially effective in inhibiting aspirin responses in aspirin sensitive asthmatics. Ann. Allergy Asthma Immunol. 85, 477–482.
Nizankowska, E., Dworski, R., Soja, J., and Szczeklik, A. (1990), Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients. Clin. Exp. Allergy 20, 647–652.
Nizankowska, E., Bestynska-Krypel, A., Cmiel, A., and Szczeklik, A. (2000), Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur. Respir. J. 15, 863–869.
Patriarca, G., Nucera, E., and Di Rienzo, V. (1991), Nasal provocation test with lysine acetylsalicylate (LAS) in aspirin-sensitive patients. Ann. Allergy 67, 60–62.
Pawlowicz, A., Williams, W. R., and Davies, B. H. (1991), Inhalation and nasal challenge in the diagnosis of aspirin induced asthma. Allergy 46, 405–409.
Schapowal, A., S.-S. M., Szczeklik, A., Bruijnzeel, P., Hansel, T., and Virchovsen, Chr. (1990), Lysineaspirin nasal provocation and anterior rhinomanometry for the diagnosis of aspirinsensitive asthma. Atemwegs. Lungenkrankh 16, S1-S5.
Wellbrock, M. M. J., Cornelius, M., and Brasch, J. (1993), Intranasal provocation with lysine acetylsalicylic acid. HNO 41, 577–581.
Milewski, M., Mastalerz, L., Nizankowska, E., and Szczeklik, A. (1998), Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J. Allergy Clin. Immunol. 101, 581–586.
Szczeklik, A. and Serwonska, M. (1979), Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clematine. Thorax 34, 654–658.
Szczeklik, A., Mastalerz, L., Nizankowska, E., and Cmiel, A. (1996), Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am. J. Respir. Crit. Care Med. 153, 567–571.
Szczeklik, A., Dworski, R., Mastalerz, L., Prokop, A., Sheller, J., Nizankowska, E., et al. (1998), Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Am. J. Respir. Crit. Care Med. 158, 1168–1172.
Martelli, N. A. U. G. (1977), Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation. Thorax 32, 684.
Basomba, A. R. A., Pelaez, A., Villalmanzo, I. G., and Campos, A. (1976), The effect of sodium cromoglycate in preventing aspirin induced bronchospasm. Clin. Allergy 6, 269.
Stevenson, D. D., Simon, R. A., and Mathison, D. A., (1984), Cromolyn pretreatment delays onset of aspirin (ASA) induced asthmatic reactions. J. Allergy Clin. Immunol. 73, 162.
Pauls, J. D., Simon, R. A., Daffern, P. J., Stevenson, D. D. (2000), Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics. Ann. Allergy Asthma Immunol. 85, 40–45.
Berges-Gimeno, M., Simon, R. A., and Stevenson, D. D. (2002), The effect of leukotriene modifier drugs on ASA-induced asthma and rhinitis reactions. Clin. Exp. Allergy (Accepted for publication.)
Szczeklik, A., Nizankowska, E., and Duplaga, M. (2000), Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur. Respir. J. 16, 432–436.
Vento, S. I., Ertama, L. O., Hytonen, M. L., Wolff, C. H. J., Malmberg, C. H. J. (2000), Nasal polyps: clinical course during 20 years. Ann. Allergy Asthma Immunol. 85, 209–214.
Author information
Authors and Affiliations
Additional information
Formerly Scripps Clinic and Green Hospital, La Jolla, CA
Rights and permissions
About this article
Cite this article
Fahrenholz, J.M. Natural history and clinical features of aspirin-exacerbated respiratory disease. Clinic Rev Allerg Immunol 24, 113–124 (2003). https://doi.org/10.1385/CRIAI:24:2:113
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:24:2:113